Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the MAGEA3-marker

Details for Australian Patent Application No. 2007263019 (hide)

Owner GlaxoSmithKline Biologicals s.a

Inventors Stephens, Craig Lawrence; Coche, Thierry; Salonga, Dennis; Gruselle, Olivier; Beer, Gabriele Anne-Marie

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007263019

PCT Pub. Number WO2007/147876

Priority 0612342.6 21.06.06 GB

Filing date 21 June 2007

Wipo publication date 27 December 2007

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

22 January 2009 PCT application entered the National Phase

  PCT publication WO2007/147876 Priority application(s): WO2007/147876

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007263020-Method of joining a pair of tubular ends

2007263018-Alkylphospholipids as active agents for prevention of plant pathogens